Introducing Tolagen: A New Path Forward in Autoimmune Disease Treatment

Today marks the beginning of a bold new chapter in the future of immune health.

We’re proud to officially introduce Tolagen, a biotech company pioneering a new class of oral tolerogenic therapies that go beyond symptom management to target the root of immune dysregulation. Backed by cutting-edge science and guided by a mission to rebalance the immune system at its core, Tolagen is transforming how chronic inflammatory and autoimmune diseases are treated.

Our approach is simple in concept—but groundbreaking in execution:
Transforming autoimmune disease treatment from management to remission at the root of dysregulation.

Why Tolagen?

Autoimmune diseases like Celiac Disease, Inflammatory Bowel Disease (IBD), and Type 1 Diabetes affect millions of people worldwide, and current treatments often focus on symptom suppression rather than true disease modification. That’s where Tolagen comes in.

Leveraging a biomimetic nanomedicine platform, we’re developing therapies that specifically target antigen-presenting cells (APCs) in the gastrointestinal tract—key regulators of immune tolerance. Our orally delivered nanoparticles are designed to mimic the size and surface of natural bacteria, prompting APCs to restore balance in immune signaling without triggering harmful inflammation.

The result? A more precise, safer, and scalable solution to help move autoimmune care into an entirely new era.

What Makes Us Different?

We’re not just another immunotherapy startup. Here’s what sets Tolagen apart:

• Root-Cause Targeting – We don’t suppress the immune system; we guide it back to balance.

• Oral Delivery – Patient-friendly dosing that improves accessibility and adherence.

• Precision-Focused Platform – Our therapies are designed to minimize off-target effects and reduce toxicity.

• NIH-Backed Science – Our platform is supported by $1.5M in NIH SBIR grants to advance preclinical research and in vivo proof-of-concept.

• Expert-Led – Tolagen is led by a founding team of experienced immunologists and biotech innovators committed to reshaping immune health.

This is just the beginning—and we’re building a future where chronic autoimmune diseases are not managed, but truly reversed at their root.

Welcome to Tolagen.